Teams responsible for setting strategy in a therapeutic area face many challenges, starting with selecting diseases to assess, evaluating the clinical and commercial merit of specific R&D programs targeted to those diseases, and helping management decide which programs to fund and which to eliminate. We have years of experience working with client teams to elicit insights that inform their strategy.

Disease Target Assessment: Identifying Opportunity

Equinox Group’s Disease Target Assessment tools help:

• Cost effectively screen large number of diseases for strategic fit
• Identify the clinical attributes that represent the best targets for differentiation in selected diseases
• Evaluate the clinical innovation potential of internal and external R&D programs and the implications for their commercial potential
• Bridge the divides that can arise among discovery, development, and commercial teams, helping create consensus to set goals and monitor progress over time
• Gain an early read on reimbursement potential and how payers are likely to value trade-offs among product attributes